Generate a tailored SOP for Dr. David Van Mater. Improve your application with a focused, well-structured draft.
David Sinclaire Van Mater is an Associate Professor in Pediatrics and a member of the Duke Cancer Institute. He specializes in pediatric oncology with a specific focus on hereditary cancer syndromes and sarcoma. He is the director of the Duke Comprehensive Neurofibromatosis Clinic, where he sees both children and adults with neurofibromatosis type II, and has additional expertise in schwannomatosis. Dr. Van Mater completed his Pediatric Hematology/Oncology Fellowship at Duke University School of Medicine and has held previous appointments as an Assistant Professor and Medical Instructor in the Department of Pediatrics. His research includes developing evidence-based criteria for initiating treatment for NF1-OPG, exploring the use of gene therapies to treat neurofibromatosis type I, and targeting epigenetic dysregulation in pediatric cancer. He has received numerous grants to support his research from prominent foundations and institutes, reflecting his commitment to improving outcomes for pediatric patients. Through his work, he contributes significantly to the field of pediatric hematology and oncology, particularly in relation to neurofibromatosis and other related conditions.
Duke University • Durham, NC
Member of Duke Cancer Institute specializing in pediatric oncology.
Duke Comprehensive Neurofibromatosis Clinic • Durham, NC
Overseeing treatment and care for patients with neurofibromatosis.
Duke University • Durham, NC
Involved in teaching and research in the Department of Pediatrics.
Department of Pediatrics • Duke University, Durham, NC
Teaching medical students in pediatric hematology and oncology.
Department of Biomedical Engineering (MS program)